Ly49 receptors: Evolution, genetic diversity, and impact on immunity

Immunological Reviews

Volumn 267, Issue 1, 2015, Pages 137-147

  Rahim, Mir Munir A ^a   Makrigiannis, Andrew P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Ly49; MHC I; Receptor:ligand co evolution

Indexed keywords

LY49 RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; BENIGN TUMOR; CELL FUNCTION; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; GENE CLUSTER; GENE LOCATION; GENE LOCUS; GENE NUMBER; GENETIC VARIABILITY; HAPLOTYPE; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNITY; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOGENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNAL TRANSDUCTION; STOP CODON; ANIMAL; GENETIC VARIATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR EVOLUTION; MOUSE;

ANIMALS; EVOLUTION, MOLECULAR; GENETIC VARIATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY; KILLER CELLS, NATURAL; MICE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; RECEPTORS, KIR;

EID: 84939526754     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12318     Document Type: Article

References (89)

1. Hirano M, Das S, Guo P, Cooper MD. The evolution of adaptive immunity in vertebrates. Adv Immunol 2011;109:125-157.
2. Kelley J, Walter L, Trowsdale J. Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet 2005;1:129-139.
3. Kumanovics A, Takada T, Lindahl KF. Genomic organization of the mammalian Mhc. Annu Rev Immunol 2003;21:629-657.
4. Valiante NM, Lienert K, Shilling HG, Smits BJ, Parham P. Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev 1997;155:155-164.
5. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23:225-274.
6. Hanke T, et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 1999;11:67-77.
7. Franksson L, Sundback J, Achour A, Bernlind J, Glas R, Karre K. Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur J Immunol 1999;29:2748-2758.
8. Tormo J, Natarajan K, Margulies DH, Mariuzza RA. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 1999;402:623-631.
9. Scarpellino L, et al. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis. J Immunol 2007;178:1277-1284.
10. Michaelsson J, Achour A, Rolle A, Karre K. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta(2)-microglobulin subunit. J Immunol 2001;166:7327-7334.
11. McFall E, et al. Optimized tetramer analysis reveals Ly49 promiscuity for MHC ligands. J Immunol 2013;191:5722-5729.
12. Johansson S, et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med 2005;201:1145-1155.
13. Brodin P, Lakshmikanth T, Johansson S, Karre K, Hoglund P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 2009;113:2434-2441.
14. Andrews DM, et al. Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Nat Immunol 2012;13:1171-1177.
15. Kim S, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005;436:709-713.
16. Held W, Kunz B. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur J Immunol 1998;28:2407-2416.
17. Olcese L, et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 1996;156:4531-4534.
18. Vivier E, Daeron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997;18:286-291.
19. Vely F, Vivier E. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J Immunol 1997;159:2075-2077.
20. Mason LH, Gosselin P, Anderson SK, Fogler WE, Ortaldo JR, McVicar DW. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J Immunol 1997;159:4187-4196.
21. D'Ambrosio D, et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 1995;268:293-297.
22. Nakamura MC, Niemi EC, Fisher MJ, Shultz LD, Seaman WE, Ryan JC. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med 1997;185:673-684.
23. Mason LH, et al. Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol 1998;160:4148-4152.
24. Smith KM, Wu J, Bakker AB, Phillips JH, Lanier LL. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol 1998;161:7-10.
25. Gosselin P, Mason LH, Willette-Brown J, Ortaldo JR, McVicar DW, Anderson SK. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J Leukoc Biol 1999;66:165-171.
26. Makrigiannis AP, et al. Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol 1999;163:4931-4938.
27. Brown MG, et al. A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics 1997;42:16-25.
28. Hao L, Nei M. Genomic organization and evolutionary analysis of Ly49 genes encoding the rodent natural killer cell receptors: rapid evolution by repeated gene duplication. Immunogenetics 2004;56:343-354.
29. Westgaard IH, Berg SF, Orstavik S, Fossum S, Dissen E. Identification of a human member of the Ly-49 multigene family. Eur J Immunol 1998;28:1839-1846.
30. Mager DL, McQueen KL, Wee V, Freeman JD. Evolution of natural killer cell receptors: coexistence of functional Ly49 and KIR genes in baboons. Curr Biol 2001;11:626-630.
31. McQueen KL, Wilhelm BT, Harden KD, Mager DL. Evolution of NK receptors: a single Ly49 and multiple KIR genes in the cow. Eur J Immunol 2002;32:810-817.
32. Gagnier L, Wilhelm BT, Mager DL. Ly49 genes in non-rodent mammals. Immunogenetics 2003;55:109-115.
33. Takahashi T, et al. Natural killer cell receptors in the horse: evidence for the existence of multiple transcribed LY49 genes. Eur J Immunol 2004;34:773-784.
34. Wong S, Freeman JD, Kelleher C, Mager D, Takei F. Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. J Immunol 1991;147:1417-1423.
35. Takei F, Brennan J, Mager DL. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol Rev 1997;155:67-77.
36. Wilhelm BT, Gagnier L, Mager DL. Sequence analysis of the ly49 cluster in C57BL/6 mice: a rapidly evolving multigene family in the immune system. Genomics 2002;80:646-661.
37. Makrigiannis AP, Pau AT, Schwartzberg PL, McVicar DW, Beck TW, Anderson SK. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 2002;79:437-444.
38. Proteau MF, Rousselle E, Makrigiannis AP. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics 2004;84:669-677.
39. Makrigiannis AP, Patel D, Goulet ML, Dewar K, Anderson SK. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun 2005;6:71-83.
40. Belanger S, Tai LH, Anderson SK, Makrigiannis AP. Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun 2008;9:509-521.
41. Ortaldo JR, Mason AT, Winkler-Pickett R, Raziuddin A, Murphy WJ, Mason LH. Ly-49 receptor expression and functional analysis in multiple mouse strains. J Leukoc Biol 1999;66:512-520.
42. Yokoyama WM, Jacobs LB, Kanagawa O, Shevach EM, Cohen DI. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J Immunol 1989;143:1379-1386.
43. Chan PY, Takei F. Molecular cloning and charac-terization of a novel murine T cell surface antigen, YE1/48. J Immunol 1989;142:1727-1736.
44. Yokoyama WM, Kehn PJ, Cohen DI, Shevach EM. Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1.1 antigen. J Immunol 1990;145:2353-2358.
45. Wilson MJ, et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 2000;97:4778-4783.
46. Anderson SK, Dewar K, Goulet ML, Leveque G, Makrigiannis AP. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes Immun 2005;6:481-492.
47. McQueen KL, Freeman JD, Takei F, Mager DL. Localization of five new Ly49 genes, including three closely related to Ly49c. Immunogenetics 1998;48:174-183.
48. Depatie C, et al. Sequence-ready BAC contig, physical, and transcriptional map of a 2-Mb region overlapping the mouse chromosome 6 host-resistance locus Cmv1. Genomics 2000;66:161-174.
49. Kazazian HH Jr. Mobile elements: drivers of genome evolution. Science 2004;303:1626-1632.
50. Toyama-Sorimachi N, et al. Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc Natl Acad Sci USA 2004;101:1016-1021.
51. Toomey JA, et al. MHC class I expression protects target cells from lysis by Ly49-deficient fetal NK cells. Eur J Immunol 1998;28:47-56.
52. Van Beneden K, et al. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. J Immunol 2001;166:4302-4311.
53. Gays F, et al. Ly49B is expressed on multiple subpopulations of myeloid cells. J Immunol 2006;177:5840-5851.
54. Wilhelm BT, Mager DL. Rapid expansion of the Ly49 gene cluster in rat. Genomics 2004;84:218-221.
55. Nylenna O, et al. The genes and gene organization of the Ly49 region of the rat natural killer cell gene complex. Eur J Immunol 2005;35:261-272.
56. Futas J, Horin P. Natural killer cell receptor genes in the family Equidae: not only Ly49. PLoS ONE 2013;8:e64736.
57. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986;319:675-678.
58. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 1999;18:1081-1091.
59. Ziegler H, et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 1997;6:57-66.
60. Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J Exp Med 1999;190:1285-1295.
61. Kleijnen MF, et al. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J 1997;16:685-694.
62. Babic M, et al. Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J Exp Med 2010;207:2663-2673.
63. Revilleza MJ, Wang R, Mans J, Hong MQ, Natarajan K, Margulies DH. How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J Biomed Biotechnol 2011;2011:724607.
64. Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 1990;171:1469-1483.
65. Lee SH, et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001;28:42-45.
66. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002;296:1323-1326.
67. Smith HR, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002;99:8826-8831.
68. Corbett AJ, Coudert JD, Forbes CA, Scalzo AA. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation. J Immunol 2011;186:1713-1722.
69. Forbes CA, Scalzo AA, Degli-Esposti MA, Coudert JD. Ly49C-dependent control of MCMV infection by NK cells is Cis-regulated by MHC class I molecules. PLoS Pathog 2014;10:e1004161.
70. Xie X, Dighe A, Clark P, Sabastian P, Buss S, Brown MG. Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J Virol 2007;81:229-236.
71. Kielczewska A, et al. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med 2009;206:515-523.
72. Achdout H, et al. Enhanced recognition of human NK receptors after influenza virus infection. J Immunol 2003;171:915-923.
73. Achdout H, Manaster I, Mandelboim O. Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J Virol 2008;82:8030-8037.
74. Wang B, Niu DD, Lai LY, Ren EC. p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1. Nat Commun 2013;4:2359.
75. Orr MT, Murphy WJ, Lanier LL. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 2010;11:321-327.
76. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991;253:199-202.
77. Belanger S, et al. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Blood 2012;120:592-602.
78. Kim S, et al. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA 2008;105:3053-3058.
79. Anfossi N, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006;25:331-342.
80. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-998.
81. Natali PG, et al. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc Natl Acad Sci USA 1989;86:6719-6723.
82. Goepel JR, Rees RC, Rogers K, Stoddard CJ, Thomas WE, Shepherd L. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma. Br J Cancer 1991;64:880-883.
83. McDougall CJ, et al. Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res 1990;50:8023-8027.
84. Vitale M, et al. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res 1998;58:737-742.
85. Cathro HP, Smolkin ME, Theodorescu D, Jo VY, Ferrone S, Frierson HF Jr. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas. Cancer Immunol Immunother 2010;59:465-472.
86. Mehta AM, Jordanova ES, Kenter GG, Ferrone S, Fleuren GJ. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 2008;57:197-206.
87. Tu MM, et al. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells. Cancer Res 2014;74:3684-3694.
88. Tarek N, et al. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 2012;122:3260-3270.
89. Patel R, Belanger S, Tai LH, Troke AD, Makrigiannis AP. Effect of Ly49 haplotype variance on NK cell function and education. J Immunol 2010;185:4783-4792.